Levetiracetam Oral solution

Form: Oral solution

Strength: 100 mg/mL

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

Category: Antipsychotropic Drugs

Levetiracetam Oral Solution is FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in adults and children aged 1 month and older. It complies with GMP standards, includes pediatric-specific dosing, and carries CNS adverse effect warnings. In the European Union, it is approved through national or mutual recognition procedures, requiring detailed Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). Formulations must meet bioavailability and stability criteria. The oral solution is valuable for patients with swallowing difficulties. Explore more formulations of Levetiracetam at Pharmatradz.com.